Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

Fabry disease: a review of current management strategies.

Mehta A, Beck M, Eyskens F, Feliciani C, Kantola I, Ramaswami U, Rolfs A, Rivera A, Waldek S, Germain DP.

QJM. 2010 Sep;103(9):641-59. doi: 10.1093/qjmed/hcq117. Epub 2010 Jul 21. Review.

PMID:
20660166
2.

[Fabry disease].

Kantola I, Penttinen M, Nuutila P, Viikari J.

Duodecim. 2012;128(7):729-39. Review. Finnish.

PMID:
22612023
3.

The heart in Fabry's disease.

Sheppard MN.

Cardiovasc Pathol. 2011 Jan-Feb;20(1):8-14. doi: 10.1016/j.carpath.2009.10.003. Epub 2009 Nov 17. Review.

PMID:
19919901
4.

Treatment of fabry disease: current and emerging strategies.

Rozenfeld P, Neumann PM.

Curr Pharm Biotechnol. 2011 Jun;12(6):916-22. doi: 1389-2010/11 $58.00+.00. Review.

PMID:
21235448
5.

Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy.

Desnick RJ, Brady R, Barranger J, Collins AJ, Germain DP, Goldman M, Grabowski G, Packman S, Wilcox WR.

Ann Intern Med. 2003 Feb 18;138(4):338-46. Review.

PMID:
12585833
6.

Enzyme replacement therapy in Fabry disease: clinical implications.

Breunig F, Knoll A, Wanner C.

Curr Opin Nephrol Hypertens. 2003 Sep;12(5):491-5. Review.

PMID:
12920395
7.

Anderson-Fabry disease: developments in diagnosis and treatment.

Mehta AB.

Int J Clin Pharmacol Ther. 2009;47 Suppl 1:S66-74. Review.

PMID:
20040315
8.

Fabry disease: recent advances in enzyme replacement therapy.

Germain DP.

Expert Opin Investig Drugs. 2002 Oct;11(10):1467-76. Review.

PMID:
12387706
9.

[Fabry disease. An interdisciplinary challenge].

Cybulla M, Neumann HP.

Dtsch Med Wochenschr. 2007 Oct;132(43):2271-7. Review. German.

PMID:
17940933
10.

Recommendations and guidelines for the diagnosis and treatment of Fabry nephropathy in adults.

Ortiz A, Oliveira JP, Wanner C, Brenner BM, Waldek S, Warnock DG.

Nat Clin Pract Nephrol. 2008 Jun;4(6):327-36. doi: 10.1038/ncpneph0806. Epub 2008 Apr 22.

PMID:
18431378
11.

Fabry disease: treatment and diagnosis.

Rozenfeld PA.

IUBMB Life. 2009 Nov;61(11):1043-50. doi: 10.1002/iub.257.

12.

Fabry disease: raising awareness of the disease among physicians.

Carubbi F, Bonilauri L.

Intern Emerg Med. 2012 Oct;7 Suppl 3:S227-31. doi: 10.1007/s11739-012-0821-x. Review.

PMID:
23073862
13.

End-stage renal disease in patients with Fabry disease: natural history data from the Fabry Registry.

Ortiz A, Cianciaruso B, Cizmarik M, Germain DP, Mignani R, Oliveira JP, Villalobos J, Vujkovac B, Waldek S, Wanner C, Warnock DG.

Nephrol Dial Transplant. 2010 Mar;25(3):769-75. doi: 10.1093/ndt/gfp554. Epub 2009 Oct 21.

PMID:
19846394
14.

Dialysis and transplantation in Fabry disease: indications for enzyme replacement therapy.

Mignani R, Feriozzi S, Schaefer RM, Breunig F, Oliveira JP, Ruggenenti P, Sunder-Plassmann G.

Clin J Am Soc Nephrol. 2010 Feb;5(2):379-85. doi: 10.2215/CJN.05570809. Epub 2010 Jan 7. Review.

15.

Therapeutic goals in the treatment of Fabry disease.

Mehta A, West ML, Pintos-Morell G, Reisin R, Nicholls K, Figuera LE, Parini R, Carvalho LR, Kampmann C, Pastores GM, Lidove O.

Genet Med. 2010 Nov;12(11):713-20. doi: 10.1097/GIM.0b013e3181f6e676.

PMID:
20975569
16.

Update on Fabry disease: kidney involvement, renal progression and enzyme replacement therapy.

Breunig F, Wanner C.

J Nephrol. 2008 Jan-Feb;21(1):32-7. Review.

PMID:
18264934
17.

Fabry disease: enzyme replacement therapy.

Bongiorno MR, Pistone G, Aricò M.

J Eur Acad Dermatol Venereol. 2003 Nov;17(6):676-9.

PMID:
14761135
18.

Fabry disease in children and response to enzyme replacement therapy: results from the Fabry Outcome Survey.

Ramaswami U, Parini R, Pintos-Morell G, Kalkum G, Kampmann C, Beck M; FOS Investigators.

Clin Genet. 2012 May;81(5):485-90. doi: 10.1111/j.1399-0004.2011.01671.x. Epub 2011 Apr 25.

PMID:
21457233
19.

The role of ceramide trihexoside (globotriaosylceramide) in the diagnosis and follow-up of the efficacy of treatment of Fabry disease: a review of the literature.

Bekri S, Lidove O, Jaussaud R, Knebelmann B, Barbey F.

Cardiovasc Hematol Agents Med Chem. 2006 Oct;4(4):289-97. Review.

PMID:
17073606
20.

[Management of Fabry disease].

Constantin T, Székely A, Ponyi A, Gulácsy V, Ambrus C, Kádár K, Vastagh I, Dajnoki A, Tóth B, Bokrétás G, Müller V, Katona M, Medvecz M, Fiedler O, Széchey R, Varga E, Rudas G, Kertész A, Molnár S, Kárpáti S, Nagy V, Magyar P, Mahdi M, Rákóczi E, Németh K, Bereczki D, Garami M, Erdos M, Maródi L, Fekete G.

Orv Hetil. 2010 Aug 1;151(31):1243-51. doi: 10.1556/OH.2010.28796. Review. Hungarian.

PMID:
20656661

Supplemental Content

Support Center